Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
Peking Union Medical College Hospital, Beijing Last updated February 2026